Avanos Medical Appoints David Pacitti as New CEO to Drive Growth and Innovation
- Avanos Medical appoints David Pacitti as CEO, effective April 14, 2025, to drive growth and innovation.
- Pacitti brings extensive experience in medical technology, previously leading Siemens Medical Solutions and Abbott Vascular.
- His leadership aims to enhance Avanos' mission to improve patient quality of life through innovative medical devices.
Avanos Medical Appoints New CEO to Drive Strategic Growth
Avanos Medical, Inc., a leading medical technology firm headquartered in Alpharetta, Georgia, announces the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025. With a robust background in the medical device industry, Pacitti is poised to guide Avanos through its next phase of growth and innovation. His previous experience as president of Siemens Medical Solutions USA, Inc. is particularly noteworthy, where he played a pivotal role in advancing strategic growth and operational efficiency across North America and Latin America. His extensive knowledge of medical imaging and laboratory diagnostics is expected to bring significant insights to Avanos’ diverse product portfolio.
Pacitti’s track record in the medical technology sector includes a successful tenure at Abbott Vascular, where he held various leadership roles and contributed to the launch of groundbreaking products, such as the drug-eluting stent franchise. His early career at Guidant Corp. further solidified his expertise in the industry. The board of directors at Avanos, led by chair Gary Blackford, confidently endorses Pacitti’s leadership capabilities, believing that his strategic vision is essential in navigating the company’s future. This leadership change comes at a critical time as Avanos continues to focus on delivering innovative solutions that directly address pressing healthcare needs.
In his statement, Pacitti expresses his honor in leading Avanos and emphasizes the company's mission to enhance patients' quality of life through advanced medical device solutions. His appointment signals a commitment to not only maintain but also to elevate Avanos’ standing within the medical technology space. The company aims to leverage Pacitti’s expertise to drive stakeholder value and continue its tradition of excellence, ensuring that it remains at the forefront of the industry.
In addition to his role at Siemens, Pacitti has served on several influential boards, including that of the AdvaMed Medical Imaging Technology Division and Orchestra BioMed, further showcasing his deep involvement in the medical technology community. His academic credentials, featuring a bachelor's degree from Villanova University and an MBA from the University of Maryland, complement his practical experience, positioning him as a well-rounded leader ready to tackle the challenges ahead for Avanos Medical.
As Avanos Medical prepares for this transition, stakeholders are hopeful that Pacitti's leadership will catalyze the company’s growth trajectory, enhancing its ability to innovate and meet the evolving needs of healthcare providers and patients alike.